IBDEI2LV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,560,0)
 ;;=LIVER^3^50
 ;;^UTILITY(U,$J,358.4,561,0)
 ;;=PANCREAS^4^50
 ;;^UTILITY(U,$J,358.4,562,0)
 ;;=SMALL INTESTINE^5^50
 ;;^UTILITY(U,$J,358.4,563,0)
 ;;=STOMACH^6^50
 ;;^UTILITY(U,$J,358.4,564,0)
 ;;=POST SURGERY STATES^7^50
 ;;^UTILITY(U,$J,358.4,565,0)
 ;;=SYMPTOMS^8^50
 ;;^UTILITY(U,$J,358.4,566,0)
 ;;=SCREENING^9^50
 ;;^UTILITY(U,$J,358.4,567,0)
 ;;=NEW PATIENT HOME VISIT^2^51
 ;;^UTILITY(U,$J,358.4,568,0)
 ;;=ESTAB PATIENT HOME VISIT^1^51
 ;;^UTILITY(U,$J,358.4,569,0)
 ;;=TEAM CONFERENCE^8^52
 ;;^UTILITY(U,$J,358.4,570,0)
 ;;=PROCEDURE CODE^6^52
 ;;^UTILITY(U,$J,358.4,571,0)
 ;;=EDUCATION/TRAINING^1^52
 ;;^UTILITY(U,$J,358.4,572,0)
 ;;=IMMUNIZATIONS^2^52
 ;;^UTILITY(U,$J,358.4,573,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^3^52
 ;;^UTILITY(U,$J,358.4,574,0)
 ;;=SKIN TEST^7^52
 ;;^UTILITY(U,$J,358.4,575,0)
 ;;=PREVENTIVE MED-EST PT^4^52
 ;;^UTILITY(U,$J,358.4,576,0)
 ;;=PREVENTIVE MED-NEW PT^5^52
 ;;^UTILITY(U,$J,358.4,577,0)
 ;;=PC COMMON DIAGNOSES^1^53
 ;;^UTILITY(U,$J,358.4,578,0)
 ;;=ADMINISTRATIVE TOPICS^2^53
 ;;^UTILITY(U,$J,358.4,579,0)
 ;;=ANGINA^3^53
 ;;^UTILITY(U,$J,358.4,580,0)
 ;;=ATHEROSCLEROSIS^4^53
 ;;^UTILITY(U,$J,358.4,581,0)
 ;;=CARDIOVASCULAR^5^53
 ;;^UTILITY(U,$J,358.4,582,0)
 ;;=DERMATOLOGY^9^53
 ;;^UTILITY(U,$J,358.4,583,0)
 ;;=EAR DISORDERS^10^53
 ;;^UTILITY(U,$J,358.4,584,0)
 ;;=EENT^11^53
 ;;^UTILITY(U,$J,358.4,585,0)
 ;;=ENDOCRINE/METABOLIC^12^53
 ;;^UTILITY(U,$J,358.4,586,0)
 ;;=EYE DISORDERS^13^53
 ;;^UTILITY(U,$J,358.4,587,0)
 ;;=EYE INJURY^14^53
 ;;^UTILITY(U,$J,358.4,588,0)
 ;;=GASTROENTEROLOGY^15^53
 ;;^UTILITY(U,$J,358.4,589,0)
 ;;=GU/RENAL^16^53
 ;;^UTILITY(U,$J,358.4,590,0)
 ;;=HEADACHE^17^53
 ;;^UTILITY(U,$J,358.4,591,0)
 ;;=HEART FAILURE^18^53
 ;;^UTILITY(U,$J,358.4,592,0)
 ;;=HEART VALVE DISEASE^19^53
 ;;^UTILITY(U,$J,358.4,593,0)
 ;;=HEMATOLOGY/ONCOLOGY^20^53
 ;;^UTILITY(U,$J,358.4,594,0)
 ;;=HISTORY OF ILLNESS^21^53
 ;;^UTILITY(U,$J,358.4,595,0)
 ;;=INFECTIOUS DISEASE^22^53
 ;;^UTILITY(U,$J,358.4,596,0)
 ;;=LIVER DISEASE^23^53
 ;;^UTILITY(U,$J,358.4,597,0)
 ;;=MENTAL HEALTH^25^53
 ;;^UTILITY(U,$J,358.4,598,0)
 ;;=MOVEMENT DISORDERS^26^53
 ;;^UTILITY(U,$J,358.4,599,0)
 ;;=MUSCULOSKELETAL^27^53
 ;;^UTILITY(U,$J,358.4,600,0)
 ;;=NEUROLOGY^28^53
 ;;^UTILITY(U,$J,358.4,601,0)
 ;;=PAIN^29^53
 ;;^UTILITY(U,$J,358.4,602,0)
 ;;=PREVENTIVE HEALTH^30^53
 ;;^UTILITY(U,$J,358.4,603,0)
 ;;=PULMONARY^31^53
 ;;^UTILITY(U,$J,358.4,604,0)
 ;;=SEXUAL TRAUMA^32^53
 ;;^UTILITY(U,$J,358.4,605,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^33^53
 ;;^UTILITY(U,$J,358.4,606,0)
 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^34^53
 ;;^UTILITY(U,$J,358.4,607,0)
 ;;=SUBSTANCE DISORDERS^35^53
 ;;^UTILITY(U,$J,358.4,608,0)
 ;;=VARICOSE VEINS^36^53
 ;;^UTILITY(U,$J,358.4,609,0)
 ;;=WOMEN'S HEALTH^37^53
 ;;^UTILITY(U,$J,358.4,610,0)
 ;;=WOUNDS-INITIAL ENCOUNTER^38^53
 ;;^UTILITY(U,$J,358.4,611,0)
 ;;=COMA^7^53
 ;;^UTILITY(U,$J,358.4,612,0)
 ;;=CAUSES OF INJURY^6^53
 ;;^UTILITY(U,$J,358.4,613,0)
 ;;=DEMENTIA^8^53
 ;;^UTILITY(U,$J,358.4,614,0)
 ;;=LONG TERM CURRENT DRUG THERAPY^24^53
 ;;^UTILITY(U,$J,358.4,615,0)
 ;;=HOME VISITS-NURSING^1^54
 ;;^UTILITY(U,$J,358.4,616,0)
 ;;=PULSE OXIMETRY^12^55
 ;;^UTILITY(U,$J,358.4,617,0)
 ;;=BLOOD PRESSURE READING^2^55
 ;;^UTILITY(U,$J,358.4,618,0)
 ;;=SELF-CARE MANAGEMENT^13^55
 ;;^UTILITY(U,$J,358.4,619,0)
 ;;=INJECTIONS^10^55
 ;;^UTILITY(U,$J,358.4,620,0)
 ;;=INJECTION ADMINISTRATION^9^55
 ;;^UTILITY(U,$J,358.4,621,0)
 ;;=IMMUNIZATIONS^8^55
 ;;^UTILITY(U,$J,358.4,622,0)
 ;;=IMMUNIZATION ADMINISTRATION^7^55
 ;;^UTILITY(U,$J,358.4,623,0)
 ;;=USE OF INHALER^16^55
